Alpha 2.0
Login Register
» Authors » M L Zighetti

M L Zighetti

Explore the profile of M L Zighetti including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 117
Followers 0
Related Specialties
Hematology
Cardiology & Vascular Diseases
Oncology
Top 10 Co-Authors
M Cattaneo
P M Mannucci
R Lombardi
A Lecchi
I Martinelli
G Carpani
C Gachet
M Mezzetti
S Saibeni
F I Pareti
Published In
Arterioscler Thromb Vasc Biol
Thromb Haemost
Br J Haematol
Thromb Res
Cardiologia
Affiliations
Soon will be listed here.
Recent Articles
1.
Partial inhibition of platelet aggregation by nebulized pentamidine in severe haemophiliacs
Cattaneo M, Lecchi A, Tradati F, Lombardi R, Zighetti M, Guarneri D, et al.
Haemophilia . 2016 May; 3(1):31-4. PMID: 27214616
The antiparasite agent pentamidine has been shown to inhibit human platelet aggregation in vitro at concentrations that (potentially) may be attained in patient plasma after the administration of the drug...
2.
Usefulness of a flow cytometric analysis of intraplatelet vasodilator-stimulated phosphoprotein phosphorylation for the detection of patients with genetic defects of the platelet P2Y(12) receptor for ADP
Zighetti M, Carpani G, Sinigaglia E, Cattaneo M
J Thromb Haemost . 2010 Aug; 8(10):2332-4. PMID: 20695985
No abstract available.
3.
Effects of surgical stress and nitrous oxide anaesthesia on peri-operative plasma levels of total homocysteine. A randomised, controlled study in general surgery
Foschi D, Rizzi A, Zighetti M, Bissi M, Corsi F, Trabucchi E, et al.
Anaesthesia . 2001 Jul; 56(7):676-9. PMID: 11437770
Previous studies of patients have shown that anaesthesia with nitrous oxide (N2O) increases the plasma levels of total homocysteine. In a randomised, controlled trial we measured the plasma total homocysteine...
4.
Platelets from a patient heterozygous for the defect of P2CYC receptors for ADP have a secretion defect despite normal thromboxane A2 production and normal granule stores: further evidence that some cases of platelet 'primary secretion defect' are...
Cattaneo M, Lecchi A, Lombardi R, Gachet C, Zighetti M
Arterioscler Thromb Vasc Biol . 2000 Nov; 20(11):E101-6. PMID: 11073862
Two unrelated patients with a congenital bleeding diathesis associated with a severe defect of the platelet ADP receptor coupled to adenylate cyclase (P2(CYC)) have been described so far. In one...
5.
Evaluation of platelet function with the PFA-100 system in patients with congenital defects of platelet secretion
Cattaneo M, Lecchi A, Agati B, Lombardi R, Zighetti M
Thromb Res . 1999 Dec; 96(3):213-7. PMID: 10588464
The template bleeding time is still the screening test for defects of platelet function, although it is an invasive and poorly reproducible technique. The PFA-100 measures platelet function at high...
6.
[A hyperhomocysteinemia study in a population with a familial factor for acute myocardial infarct and sudden cardiac death at a young age]
Bollani G, Ferrari R, Bersatti F, Ferrari M, Cattaneo M, Zighetti M, et al.
Cardiologia . 1999 Apr; 44(1):75-81. PMID: 10188334
The alterations of the metabolism of methionine determining an accumulation of homocysteine in blood (hyperhomocysteinemia) recognize a multifactorial etiology, hereditary as well as acquired. To date several case-control studies have...
7.
Is the oral methionine loading test insensitive to the remethylation pathway of homocysteine?
Cattaneo M, Lombardi R, Lecchi A, Zighetti M
Blood . 1999 Feb; 93(3):1118-20. PMID: 10025987
No abstract available.
8.
High prevalence of hyperchomocysteinemia in patients with inflammatory bowel disease: a pathogenic link with thromboembolic complications?
Cattaneo M, Vecchi M, Zighetti M, Saibeni S, Martinelli I, Omodei P, et al.
Thromb Haemost . 1998 Nov; 80(4):542-5. PMID: 9798965
Background And Aims: Why patients with inflammatory bowel disease are at increased risk for thrombosis is unknown. Since they may have impaired absorption of vitamins that regulate the metabolism of...
9.
Plasma levels of activated protein C in healthy subjects and patients with previous venous thromboembolism: relationships with plasma homocysteine levels
Cattaneo M, Franchi F, Zighetti M, Martinelli I, Asti D, Mannucci P
Arterioscler Thromb Vasc Biol . 1998 Sep; 18(9):1371-5. PMID: 9743224
The proteolytic enzyme activated protein C (APC) is a normal plasma component, indicating that protein C (PC) is continuously activated in vivo. High concentrations of homocysteine (Hcy) inhibit the activation...
10.
Tamoxifen reduces plasma homocysteine levels in healthy women
Cattaneo M, Baglietto L, Zighetti M, Bettega D, Robertson C, Costa A, et al.
Br J Cancer . 1998 Jul; 77(12):2264-6. PMID: 9649143
Treatment with tamoxifen is associated with reduced incidence of myocardial infarction. As plasma homocysteine is an independent risk factor for cardiovascular disease, we studied the effects of tamoxifen on plasma...